STEPHEN EDWARD RAPECKI

Person

SLOUGH, BERKSHIRE, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Antibody molecules which bind CD45
- Patent number 11,692,041
- Issue date Jul 4, 2023
- UCB Biopharma SRL
- Helene Margaret Finney
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of identifying potential inhibitors of APO TNFα trimers
- Patent number 11,674,967
- Issue date Jun 13, 2023
- UCB Biopharma SRL
- James Philip O'Connell
- G01 - MEASURING TESTING
Information Patent Grant
Antibody molecules which bind CD22
- Patent number 11,472,879
- Issue date Oct 18, 2022
- UCB Biopharma SRL
- Helene Margaret Finney
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Lipocalin 2 as a biomarker for IL-17 inhibitor therapy efficacy
- Patent number 11,466,324
- Issue date Oct 11, 2022
- UCB Biopharma SRL
- Adam Samuel Platt
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method for identifying a modulator of the TNFα or CD40L interaction...
- Patent number 11,448,655
- Issue date Sep 20, 2022
- UCB Biopharma SRL
- James Philip O'Connell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Molecules with specificity for CD79 and CD22
- Patent number 11,261,252
- Issue date Mar 1, 2022
- UCB Biopharma SRL
- Helene Margaret Finney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of identifying signaling modulators of the trimeric TNFa
- Patent number 10,883,996
- Issue date Jan 5, 2021
- UCB Biopharma SRL
- James Philip O'Connell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method employing bispecific antibodies
- Patent number 10,829,566
- Issue date Nov 10, 2020
- UCB Biopharma SRL
- Stephen Edward Rapecki
- G01 - MEASURING TESTING
Information Patent Grant
Treatment of autoimmune and inflammatory disorders with asymmetric...
- Patent number 10,775,385
- Issue date Sep 15, 2020
- UCB Biopharma SRL
- James Philip O'Connell
- G01 - MEASURING TESTING
Information Patent Grant
Molecules with specificity for CD45 and CD79
- Patent number 10,774,152
- Issue date Sep 15, 2020
- UCB Biopharma SPRL
- Helene Margaret Finney
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Molecules with specificity for CD45 and CD79
- Patent number 10,730,952
- Issue date Aug 4, 2020
- UCB Biopharma SPRL
- Helene Margaret Finney
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
TNF receptor signaling modulator assay
- Patent number 10,705,094
- Issue date Jul 7, 2020
- UCB Biopharma SRL
- James Philip O'Connell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody molecules which bind CD79
- Patent number 10,618,957
- Issue date Apr 14, 2020
- UCB Biopharma SPRL
- Helene Margaret Finney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody molecules which bind CD22
- Patent number 10,590,197
- Issue date Mar 17, 2020
- UCB Biopharma SPRL
- Helene Margaret Finney
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Grant
Molecules with specificity for CD79 and CD22
- Patent number 10,370,447
- Issue date Aug 6, 2019
- UCB Biopharma SPRL
- Helene Margaret Finney
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific format suitable for use in high-through-put screening
- Patent number 10,358,493
- Issue date Jul 23, 2019
- UCB Biopharma SPRL
- Helene Margaret Finney
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of treating inflammation by administering antibody molecules...
- Patent number 10,308,723
- Issue date Jun 4, 2019
- UCB Biopharma SPRL
- Ralph Adams
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Lipocalin 2 as a biomarker for IL-17 inhibitor therapy efficacy
- Patent number 10,208,349
- Issue date Feb 19, 2019
- UCB Biopharma SPRL
- Adam Samuel Platt
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods of treating an IL-17A mediated pathological condition
- Patent number 9,890,219
- Issue date Feb 13, 2018
- UCB Biopharma SPRL
- Ralph Adams
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neutralising antibody molecules having specificity for human IL-17
- Patent number 8,865,167
- Issue date Oct 21, 2014
- UCB Pharma, S.A.
- Ralph Adams
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acids encoding antibody molecules which bind IL-17A and IL-17F
- Patent number 8,617,847
- Issue date Dec 31, 2013
- UCB Pharma S.A.
- Ralph Adams
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
DNA encoding antibody molecules which bind human IL-17
- Patent number 8,435,761
- Issue date May 7, 2013
- UCB Pharma S.A.
- Stephen Edward Rapecki
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acid molecules encoding neutralising antibodies having spec...
- Patent number 8,329,431
- Issue date Dec 11, 2012
- UCB Pharma S.A.
- Ralph Adams
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody molecules which bind IL-17A and IL-17F
- Patent number 8,303,953
- Issue date Nov 6, 2012
- UCB Pharma S.A.
- Ralph Adams
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neutralising antibody molecules having specificity for human IL-17
- Patent number 8,231,875
- Issue date Jul 31, 2012
- UCB Pharma S.A.
- Ralph Adams
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody molecules which bind to human IL-17
- Patent number 8,057,794
- Issue date Nov 15, 2011
- UCB Pharma S.A.
- Stephen Edward Rapecki
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for the treatment of multiple sclerosis by inhibiting IL-17...
- Patent number 7,931,900
- Issue date Apr 26, 2011
- UCB Pharma S.A.
- Mark Ian Christie
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
BINDING MOLECULES THAT MULTIMERISE CD45
- Publication number 20230374148
- Publication date Nov 23, 2023
- UCB Biopharma SRL
- Stephen Edward RAPECKI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY MOLECULES WHICH BIND CD45
- Publication number 20230287134
- Publication date Sep 14, 2023
- UCB Biopharma SRL
- Helene Margaret FINNEY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC ANTIBODIES BINDING HVEM AND CD9
- Publication number 20230192900
- Publication date Jun 22, 2023
- UCB Biopharma SRL
- David Alan COOK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODULATOR ASSAY
- Publication number 20230194541
- Publication date Jun 22, 2023
- UCB Biopharma SRL
- James Philip O'CONNELL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC ANTIBODIES AGAINST CD9
- Publication number 20230151109
- Publication date May 18, 2023
- UCB Biopharma SRL
- David Alan COOK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIBODIES AGAINST CD9 AND CD137
- Publication number 20230151108
- Publication date May 18, 2023
- UCB Biopharma SRL
- David Alan COOK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI CD44-CTLA4 BISPECIFIC ANTIBODIES
- Publication number 20230125234
- Publication date Apr 27, 2023
- UCB Biopharma SRL
- David Alan COOK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC ANTIBODIES AGAINST CD9 AND CD7
- Publication number 20230096030
- Publication date Mar 30, 2023
- UCB Biopharma SRL
- David Alan COOK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY MOLECULES WHICH BIND CD22
- Publication number 20230065921
- Publication date Mar 2, 2023
- UCB Biopharma SRL
- Helene Margaret FINNEY
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
MECHANISM OF ACTION
- Publication number 20210140972
- Publication date May 13, 2021
- UCB Biopharma SRL
- James Philip O'CONNELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL TNFa STRUCTURE FOR USE IN THERAPY
- Publication number 20210088530
- Publication date Mar 25, 2021
- UCB Biopharma SRL
- James Philip O'CONNELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODULATOR ASSAY
- Publication number 20200400678
- Publication date Dec 24, 2020
- UCB Biopharma SRL
- James Philip O'CONNELL
- G01 - MEASURING TESTING
Information Patent Application
ANTIBODY MOLECULES WHICH BIND CD22
- Publication number 20200157215
- Publication date May 21, 2020
- UCB Biopharma SRL
- Helene Margaret FINNEY
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
MOLECULES WITH SPECIFICITY FOR CD79 AND CD22
- Publication number 20200024346
- Publication date Jan 23, 2020
- UCB Biopharma SPRL
- HELENE MARGARET FINNEY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MOLECULES WITH SPECIFICITY FOR CD45 AND CD79
- Publication number 20190359713
- Publication date Nov 28, 2019
- UCB Biopharma SPRL
- HELENE MARGARET FINNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC FORMAT SUITABLE FOR USE IN HIGH-THROUGH-PUT SCREENING
- Publication number 20190322739
- Publication date Oct 24, 2019
- UCB Biopharma SPRL
- Helene Margaret FINNEY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LIPOCALIN 2 AS A BIOMARKER FOR IL-17 INHIBITOR THERAPY EFFICACY
- Publication number 20190144945
- Publication date May 16, 2019
- UCB Biopharma SPRL
- Adam Samuel Platt
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHOD EMPLOYING BISPECIFIC ANTIBODIES
- Publication number 20180346604
- Publication date Dec 6, 2018
- UCB Biopharma SPRL
- Stephen Edward RAPECKI
- G01 - MEASURING TESTING
Information Patent Application
ANTIBODY MOLECULES WHICH BIND CD22
- Publication number 20180273620
- Publication date Sep 27, 2018
- UCB Biopharma SPRL
- HELENE MARGARET FINNEY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY MOLECULES WHICH BIND CD45
- Publication number 20180237521
- Publication date Aug 23, 2018
- UCB Biopharma SPRL
- HELENE MARGARET FINNEY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL TNFalpha STRUCTURE FOR USE IN THERAPY
- Publication number 20180231562
- Publication date Aug 16, 2018
- UCB Biopharma SPRL
- James Philip O'CONNELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY MOLECULES WHICH BIND CD79
- Publication number 20180201678
- Publication date Jul 19, 2018
- UCB Biopharma SPRL
- Helene Margaret FINNEY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MECHANISM OF ACTION
- Publication number 20180203016
- Publication date Jul 19, 2018
- UCB Biopharma SPRL
- James Philip O'CONNELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODULATOR ASSAY
- Publication number 20180172702
- Publication date Jun 21, 2018
- UCB Biopharma SPRL
- James Philip O'CONNELL
- G01 - MEASURING TESTING
Information Patent Application
Antibody Molecules Which Bind IL-17A and IL-17F
- Publication number 20170306052
- Publication date Oct 26, 2017
- UCB Pharma SA
- Ralph Adams
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEUTRALISING ANTIBODY MOLECULES HAVING SPECIFICITY FOR HUMAN IL-17
- Publication number 20170275355
- Publication date Sep 28, 2017
- UCB Biopharma SPRL
- Ralph Adams
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MOLECULES WITH SPECIFICITY FOR CD45 AND CD79
- Publication number 20170204183
- Publication date Jul 20, 2017
- UCB Biopharma SPRL
- HELENE MARGARET FINNEY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MOLECULES WITH SPECIFICITY FOR CD79 AND CD22
- Publication number 20170204178
- Publication date Jul 20, 2017
- UCB Biopharma SPRL
- HELENE MARGARET FINNEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEW BISPECIFIC FORMAT SUITABLE FOR USE IN HIGH-THROUGH-PUT SCREENING
- Publication number 20170081404
- Publication date Mar 23, 2017
- UCB Biopharma SPRL
- HELENE MARGARET FINNEY
- G01 - MEASURING TESTING
Information Patent Application
NEUTRALISING ANTIBODY MOLECULES HAVING SPECIFICITY FOR HUMAN IL-17
- Publication number 20160251429
- Publication date Sep 1, 2016
- UCB Pharma SA
- Ralph Adams
- C07 - ORGANIC CHEMISTRY

STEPHEN EDWARD RAPECKI

Person

Patents Grantslast 30 patents

Antibody molecules which bind CD45

Method of identifying potential inhibitors of APO TNFα trimers

Antibody molecules which bind CD22

Lipocalin 2 as a biomarker for IL-17 inhibitor therapy efficacy

Method for identifying a modulator of the TNFα or CD40L interaction...

Molecules with specificity for CD79 and CD22

Methods of identifying signaling modulators of the trimeric TNFa

Method employing bispecific antibodies

Treatment of autoimmune and inflammatory disorders with asymmetric...

Molecules with specificity for CD45 and CD79

Molecules with specificity for CD45 and CD79

TNF receptor signaling modulator assay

Antibody molecules which bind CD79

Antibody molecules which bind CD22

Molecules with specificity for CD79 and CD22

Bispecific format suitable for use in high-through-put screening

Method of treating inflammation by administering antibody molecules...

Lipocalin 2 as a biomarker for IL-17 inhibitor therapy efficacy

Methods of treating an IL-17A mediated pathological condition

Neutralising antibody molecules having specificity for human IL-17

Nucleic acids encoding antibody molecules which bind IL-17A and IL-17F

DNA encoding antibody molecules which bind human IL-17

Nucleic acid molecules encoding neutralising antibodies having spec...

Antibody molecules which bind IL-17A and IL-17F

Neutralising antibody molecules having specificity for human IL-17

Antibody molecules which bind to human IL-17

Method for the treatment of multiple sclerosis by inhibiting IL-17...

Patents Applicationslast 30 patents

BINDING MOLECULES THAT MULTIMERISE CD45

ANTIBODY MOLECULES WHICH BIND CD45

BISPECIFIC ANTIBODIES BINDING HVEM AND CD9

MODULATOR ASSAY

BISPECIFIC ANTIBODIES AGAINST CD9

BISPECIFIC ANTIBODIES AGAINST CD9 AND CD137

ANTI CD44-CTLA4 BISPECIFIC ANTIBODIES

BISPECIFIC ANTIBODIES AGAINST CD9 AND CD7

ANTIBODY MOLECULES WHICH BIND CD22

MECHANISM OF ACTION

NOVEL TNFa STRUCTURE FOR USE IN THERAPY

MODULATOR ASSAY

ANTIBODY MOLECULES WHICH BIND CD22

MOLECULES WITH SPECIFICITY FOR CD79 AND CD22

MOLECULES WITH SPECIFICITY FOR CD45 AND CD79

BISPECIFIC FORMAT SUITABLE FOR USE IN HIGH-THROUGH-PUT SCREENING

LIPOCALIN 2 AS A BIOMARKER FOR IL-17 INHIBITOR THERAPY EFFICACY

METHOD EMPLOYING BISPECIFIC ANTIBODIES

ANTIBODY MOLECULES WHICH BIND CD22

ANTIBODY MOLECULES WHICH BIND CD45

NOVEL TNFalpha STRUCTURE FOR USE IN THERAPY

ANTIBODY MOLECULES WHICH BIND CD79

MECHANISM OF ACTION

MODULATOR ASSAY

Antibody Molecules Which Bind IL-17A and IL-17F

NEUTRALISING ANTIBODY MOLECULES HAVING SPECIFICITY FOR HUMAN IL-17

MOLECULES WITH SPECIFICITY FOR CD45 AND CD79

MOLECULES WITH SPECIFICITY FOR CD79 AND CD22

NEW BISPECIFIC FORMAT SUITABLE FOR USE IN HIGH-THROUGH-PUT SCREENING

NEUTRALISING ANTIBODY MOLECULES HAVING SPECIFICITY FOR HUMAN IL-17